Cultured AFB Other Than Tuberculosis MOTT DST for Rapid Growers Test
Comprehensive Introduction to MOTT DST Testing
The Cultured AFB Other Than Tuberculosis MOTT DST for Rapid Growers Test represents a critical advancement in infectious disease diagnostics, specifically designed to address the growing challenge of non-tuberculous mycobacterial (NTM) infections. These rapidly growing mycobacteria, often referred to as MOTT (Mycobacteria Other Than Tuberculosis), present unique diagnostic and therapeutic challenges that require specialized testing approaches.
This sophisticated drug sensitivity testing plays a vital role in modern infectious disease management by providing healthcare providers with precise information about which antimicrobial agents will be most effective against specific MOTT strains. The importance of this testing cannot be overstated, as inappropriate antibiotic selection can lead to treatment failure, prolonged illness, and the development of drug-resistant strains.
What the Test Measures and Detects
The MOTT DST for Rapid Growers Test employs advanced Broth Microdilution (MIC) methodology to determine the minimum inhibitory concentrations of various antibiotics against rapidly growing mycobacteria. This comprehensive analysis includes:
- Detection of drug susceptibility patterns for multiple antibiotic classes
- Identification of minimum inhibitory concentrations (MIC) for targeted therapy
- Assessment of resistance mechanisms in non-tuberculous mycobacteria
- Evaluation of treatment options for complex mycobacterial infections
The test specifically targets rapidly growing mycobacterial species such as Mycobacterium abscessus, Mycobacterium fortuitum, and Mycobacterium chelonae, which are known for their rapid growth characteristics and complex resistance patterns.
Who Should Consider This Test
This specialized testing is recommended for individuals experiencing symptoms or clinical presentations suggestive of non-tuberculous mycobacterial infections, including:
- Patients with persistent respiratory symptoms unresponsive to conventional antibiotics
- Individuals with skin and soft tissue infections showing atypical characteristics
- Immunocompromised patients presenting with opportunistic infections
- Those with chronic pulmonary conditions and recurrent infections
- Patients with healthcare-associated infections following surgical procedures
- Individuals with disseminated mycobacterial infections
Specific Clinical Indications
- Chronic cough with sputum production lasting more than 3 months
- Recurrent skin abscesses or nodules
- Post-surgical wound infections with delayed healing
- Lymphadenitis in children and adults
- Disseminated infections in immunocompromised hosts
Benefits of Taking the MOTT DST Test
Undergoing the Cultured AFB Other Than Tuberculosis MOTT DST for Rapid Growers Test provides numerous clinical advantages:
- Targeted Treatment Selection: Enables healthcare providers to choose the most effective antibiotics based on specific susceptibility patterns
- Reduced Treatment Duration: Helps avoid ineffective therapies, potentially shortening overall treatment time
- Prevention of Resistance Development: Guides appropriate antibiotic use to minimize the risk of developing drug-resistant strains
- Improved Clinical Outcomes: Increases the likelihood of successful infection resolution
- Cost-Effective Care: Reduces healthcare costs by avoiding ineffective treatments and hospitalizations
- Personalized Medicine Approach: Provides individualized treatment recommendations based on specific bacterial characteristics
Understanding Your Test Results
Interpreting MOTT DST results requires careful consideration by qualified healthcare professionals. Here’s general guidance on understanding your test outcomes:
Susceptibility Interpretation
- Susceptible: The antibiotic is likely to be effective against the identified mycobacterial strain
- Intermediate: The antibiotic may be effective at higher doses or in specific clinical situations
- Resistant: The antibiotic is unlikely to be effective and alternative treatments should be considered
Clinical Application
Your healthcare provider will use the susceptibility results to design a comprehensive treatment regimen that may include multiple antibiotics. The specific combination and duration of therapy will depend on the infection site, patient factors, and the complete susceptibility profile.
Test Information and Pricing
| Test Parameter | Details |
|---|---|
| Test Name | Cultured AFB Other Than Tuberculosis MOTT DST for Rapid Growers Test |
| Discount Price | $262 USD |
| Regular Price | $376 USD |
| Turnaround Time | Sample Daily by 3:30 PM; Report 7 Days |
| Sample Type | Submit pure growth of MOTT on appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated OR when used with other AFB culture or Mycobacteria identification tests the pure growth (MOTT) obtained in the Laboratory specimens already submitted will be processed for MOTT Drug Sensitivity. |
| Pre-test Instructions | No special preparation required |
| Testing Method | Broth Microdilution (MIC) |
Nationwide Testing Availability
We have comprehensive testing facilities across the United States, with branches conveniently located in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our nationwide network ensures that patients can access this specialized testing regardless of their location.
Take Action for Your Health
Don’t let uncertainty about treatment options delay your recovery. The Cultured AFB Other Than Tuberculosis MOTT DST for Rapid Growers Test provides the critical information needed to develop an effective treatment strategy for non-tuberculous mycobacterial infections.
Book your test today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment through our online booking system. Our experienced staff is available to answer your questions and guide you through the testing process.
Take the first step toward targeted, effective treatment for mycobacterial infections. Contact us now to schedule your MOTT DST testing and receive the comprehensive diagnostic information necessary for optimal clinical management.
